News

Published on 12 Dec 2023 on Simply Wall St. via Yahoo Finance

Artivion, Inc. (NYSE:AORT) is a favorite amongst institutional investors who own 78%


Article preview image

Key Insights

Significantly high institutional ownership implies Artivion's stock price is sensitive to their trading actionsA total of 7 investors have a majority stake in the company with 50% ownership Insiders have sold recently

Every investor in Artivion, Inc. (NYSE:AORT) should be aware of the most powerful shareholder groups. With 78% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

NYSE.AORT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year

If you want to compound wealth in the stock market, you can do so by buying an index fund. But in...

Simply Wall St. via Yahoo Finance 19 Apr 2024

Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run?

Have you been paying attention to shares of Artivion (AORT)? Shares have been on the move with th...

Zacks via Yahoo Finance 29 Mar 2024

Artivion executive sells shares worth nearly $100k By Investing.com

Artivion, Inc.'s (NYSE:AORT) Vice President of Human Resources, Matthew A. Getz, has recently sol...

Investing.com 15 Mar 2024

Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024

The Medical Instruments industry is highly fragmented, with participants engaged in research and ...

Zacks via Yahoo Finance 14 Mar 2024

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 12 Mar 2024

Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?

Shares of Artivion (AORT) have been strong performers lately, with the stock up 15.9% over the pa...

Zacks via Yahoo Finance 22 Feb 2024

Artivion, Inc. (NYSE:AORT) Q4 2023 Earnings Call Transcript

Artivion, Inc. (NYSE:AORT) Q4 2023 Earnings Call Transcript February 15, 2024 Artivion, Inc. beat...

Insider Monkey via Yahoo Finance 17 Feb 2024

Earnings call: Artivion Posts Strong Growth, Expands Global Presence By Investing.com

Artivion Inc. (ticker: AORT), a medical device company, reported a robust financial performance f...

Investing.com 16 Feb 2024

Artivion, Inc. (NYSE:AORT) Soars 36% But It's A Story Of Risk Vs Reward

Artivion, Inc. (NYSE:AORT) shareholders would be excited to see that the share price has had a gr...

Simply Wall St. via Yahoo Finance 18 Dec 2023

Artivion, Inc. (NYSE:AORT) is a favorite amongst institutional investors who own 78%

Key Insights Significantly high institutional ownership implies Artivion's stock price is sensiti...

Simply Wall St. via Yahoo Finance 12 Dec 2023